X4 Pharmaceuticals (XFOR) Inventory Average (2024 - 2026)

X4 Pharmaceuticals (XFOR) has reported Inventory Average for 3 consecutive years, with $5.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Inventory Average rose 61.99% year-over-year to $5.1 million; the trailing twelve-month figure through Jun 2026 stood at $5.1 million (up 61.99% YoY), and the FY2025 full-year result was $3.6 million, changed N/A from the prior year.
• Inventory Average rose to $5.1 million in Q2 2026 per XFOR's latest filing, from $4.6 million in the prior quarter.
• Across five years, Inventory Average topped out at $5.1 million in Q2 2026 and bottomed at $1.6 million in Q3 2024.
• Historically, Inventory Average has averaged $3.5 million across 3 years, with a median of $3.4 million in 2025.
• The sharpest annual moves came in 2025 and 2026: Inventory Average surged 121.31% in 2025, then soared 54.35% in 2026.
• Over 3 years, Inventory Average stood at $2.6 million in 2024, then jumped by 62.66% to $4.3 million in 2025, then rose by 18.46% to $5.1 million in 2026.
• According to Business Quant data, Inventory Average over the past three periods registered $5.1 million, $4.6 million, and $4.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.